Check pharmacology, toxicology and pharmaceutics papers: citations, claims and retractions

GENE EXPRESSION IN HUMAN HEPATOCYTES IN SUSPENSION AFTER ISOLATION IS SIMILAR TO THE LIVER OF ORIGIN, IS NOT AFFECTED BY HEPATOCYTE COLD STORAGE AND CRYOPRESERVATION, BUT IS STRONGLY CHANGED AFTER HEPATOCYTE PLATING

Richert, L., Liguori, M. J., Abadie, C., Heyd, B., Mantion, G., Halkic, N., & Waring, J. F. (2006) · Drug Metabolism and Disposition

Drug-Induced Hepatotoxicity and ProtectionLiver physiology and pathology

Cited by 136

M-cell targeted biodegradable PLGA nanoparticles for oral immunization against hepatitis B

Gupta, P. N., Khatri, K., Goyal, A. K., Mishra, N., & Vyas, S. P. (2007) · Journal of Drug Targeting

Advanced Drug Delivery SystemsNanoparticle-Based Drug Delivery

Cited by 136

Is dialysis a reliable method for studying drug release from nanoparticulate systems?—A case study

Zambito, Y., Pedreschi, E., & Di Colo, G. (2012) · International Journal of Pharmaceutics

Advanced Drug Delivery SystemsNanoparticle-Based Drug Delivery

Cited by 136

Isolation, characterization and antioxidative effect of phyllanthin against CCl4-induced toxicity in HepG2 cell line

Krithika, R., Mohankumar, R., Verma, R. J., Shrivastav, P. S., Mohamad, I. L., Gunasekaran, P., & Narasimhan, S. (2009) · Chemico-Biological Interactions

Phytochemistry and Bioactivity StudiesDrug-Induced Hepatotoxicity and Protection

Cited by 136

Variability of CYP3A7 expression in human fetal liver

Leeder, J. S., Gaedigk, R., Marcucci, K. A., Gaedigk, A., Vyhlidal, C. A., Schindel, B. P., & Pearce, R. E. (2005) · The Journal of Pharmacology and Experimental Therapeutics

Pharmacogenetics and Drug MetabolismMetal-Catalyzed Oxygenation Mechanisms

Cited by 136

Trials and tribulations of skin iontophoresis in therapeutics

Roustit, M., Blaise, S., & Cracowski, J. (2014) · British Journal of Clinical Pharmacology

Advancements in Transdermal Drug DeliveryAdvanced Drug Delivery Systems

Cited by 136

Research Directions in the Clinical Implementation of Pharmacogenomics: An Overview of US Programs and Projects

Volpi, S., Bult, C. J., Chisholm, R. L., Deverka, P. A., Ginsburg, G. S., Jacob, H. J., Kasapi, M., McLeod, H. L., Roden, D. M., Williams, M. S., et al. (2018) · Clinical Pharmacology & Therapeutics

Pharmacogenetics and Drug MetabolismGenetic Associations and Epidemiology

Cited by 135

Oral and Intravenous Acetylcysteine for Treatment of Acetaminophen Toxicity: A Systematic Review and Meta-analysis

Green, J., Heard, K., Reynolds, K., & Albert, D. (2013) · Western Journal of Emergency Medicine

Drug-Induced Hepatotoxicity and ProtectionPoisoning and overdose treatments

Cited by 135

Sex Differences in the Expression of Drug-Metabolizing and Transporter Genes in Human Liver

Yang, L., & Li, Y. (2012) · Journal of Drug Metabolism & Toxicology

Pharmacogenetics and Drug MetabolismDrug Transport and Resistance Mechanisms

Cited by 135

Molecular Docking Screens Using Comparative Models of Proteins

Fan, H., Irwin, J. J., Webb, B. M., Klebe, G., Shoichet, B. K., & Sali, A. (2009) · Journal of Chemical Information and Modeling

Computational Drug Discovery MethodsProtein Structure and Dynamics

Cited by 135

Pharmacokinetic comparison of sublingual lorazepam with intravenous, intramuscular, and oral lorazepam

Greenblatt, D. J., Divoll, M., Harmatz, J. S., & Shader, R. I. (1982) · Journal of Pharmaceutical Sciences

Pharmacogenetics and Drug MetabolismAnesthesia and Sedative Agents

Cited by 134

Combination of argan oil and phospholipids for the development of an effective liposome-like formulation able to improve skin hydration and allantoin dermal delivery

Manca, M. L., Matricardi, P., Cencetti, C., Peris, J. E., Melis, V., Carbone, C., Escribano, E., Zaru, M., Fadda, A. M., & Manconi, M. (2016) · International Journal of Pharmaceutics

Advancements in Transdermal Drug DeliveryAdvanced Drug Delivery Systems

Cited by 134

Post-Marketing Safety Concerns with Esketamine: A Disproportionality Analysis of Spontaneous Reports Submitted to the FDA Adverse Event Reporting System

Gastaldon, C., Raschi, E., Kane, J. M., Barbui, C., & Schoretsanitis, G. (2021) · Psychotherapy and Psychosomatics

Pharmacovigilance and Adverse Drug ReactionsTreatment of Major Depression

Cited by 134

Development of proteo-chemometrics: a novel technology for the analysis of drug-receptor interactions

Lapinsh, M., Prusis, P., Gutcaits, A., Lundstedt, T., & Wikberg, J. E. S. (2001) · Biochimica et Biophysica Acta (BBA) - General Subjects

Computational Drug Discovery MethodsReceptor Mechanisms and Signaling

Cited by 134

Developing a Multi-Dose Computational Model for Drug-Induced Hepatotoxicity Prediction Based on Toxicogenomics Data

Su, R., Wu, H., Xu, B., Liu, X., & Wei, L. (2019) · IEEE/ACM Transactions on Computational Biology and Bioinformatics

Drug-Induced Hepatotoxicity and ProtectionComputational Drug Discovery Methods

Cited by 134

Poly(ethylene glycol) as stabilizer and emulsifying agent: a novel stabilization approach preventing aggregation and inactivation of proteins upon encapsulation in bioerodible polyester microspheres

Castellanos, I. (2003) · Journal of Controlled Release

Advanced Drug Delivery SystemsProteins in Food Systems

Cited by 134

CovalentDock: Automated covalent docking with parameterized covalent linkage energy estimation and molecular geometry constraints

Ouyang, X., Zhou, S., Su, C. T. T., Ge, Z., Li, R., & Kwoh, C. K. (2013) · Journal of Computational Chemistry

Computational Drug Discovery MethodsCholinesterase and Neurodegenerative Diseases

Cited by 134

Parallel Optimization of Synthetic Pathways within the Network of Organic Chemistry

Kowalik, M., Gothard, C. M., Drews, A. M., Gothard, N. A., Weckiewicz, A., Fuller, P. E., Grzybowski, B. A., & Bishop, K. J. M. (2012) · Angewandte Chemie International Edition

Computational Drug Discovery MethodsMicrobial Metabolic Engineering and Bioproduction

Cited by 134

A learning-based method for drug-target interaction prediction based on feature representation learning and deep neural network

Peng, J., Li, J., & Shang, X. (2020) · BMC Bioinformatics

Computational Drug Discovery MethodsBioinformatics and Genomic Networks

Cited by 133

PON1 and Neurodevelopment in Children from the CHAMACOS Study Exposed to Organophosphate Pesticides in Utero

Eskenazi, B., Huen, K., Marks, A., Harley, K. G., Bradman, A., Barr, D. B., & Holland, N. (2010) · Environmental Health Perspectives

Pesticide Exposure and ToxicityParaoxonase enzyme and polymorphisms

Cited by 133

Small‐molecule protein–protein interaction inhibitors: Therapeutic potential in light of molecular size, chemical space, and ligand binding efficiency considerations

Buchwald, P. (2010) · IUBMB Life

Computational Drug Discovery MethodsChemical Synthesis and Analysis

Cited by 133

Alarms about structural alerts

Alves, V. M., Muratov, E. N., Capuzzi, S. J., Politi, R., Low, Y., Braga, R. C., Zakharov, A. V., Sedykh, A., Mokshyna, E., Farag, S., et al. (2016) · Green Chemistry

Computational Drug Discovery MethodsEnvironmental Toxicology and Ecotoxicology

Cited by 133

CSAR benchmark exercise 2011–2012: evaluation of results from docking and relative ranking of blinded congeneric series.

Damm-Ganamet, K. L., Smith, R. D., Dunbar, J. B., Stuckey, J. A., & Carlson, H. A. (2013) · Journal of Chemical Information and Modeling

Computational Drug Discovery MethodsProtein Structure and Dynamics

Cited by 133

DeepDrug3D: Classification of ligand-binding pockets in proteins with a convolutional neural network

Pu, L., Govindaraj, R. G., Lemoine, J. M., Wu, H.-C., & Brylinski, M. (2019) · PLOS Computational Biology

Computational Drug Discovery MethodsProtein Structure and Dynamics

Cited by 133